APA (7th ed.) Citation

IC, G. O., SD, F., Jr, B. R., AP, F., I, J., TD, H., . . . MA, D. (2024). Author Correction: Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results. Nature medicine, 30(6), 1787. https://doi.org/10.1038/s41591-024-02998-5

Chicago Style (17th ed.) Citation

IC, Glitza Oliva, et al. "Author Correction: Concurrent Intrathecal and Intravenous Nivolumab in Leptomeningeal Disease: Phase 1 Trial Interim Results." Nature Medicine 30, no. 6 (2024): 1787. https://doi.org/10.1038/s41591-024-02998-5.

MLA (9th ed.) Citation

IC, Glitza Oliva, et al. "Author Correction: Concurrent Intrathecal and Intravenous Nivolumab in Leptomeningeal Disease: Phase 1 Trial Interim Results." Nature Medicine, vol. 30, no. 6, 2024, p. 1787, https://doi.org/10.1038/s41591-024-02998-5.